Improving Drug Safety Through Cardiotoxicity Assessment
PerkinElmer
JANUARY 7, 2022
The pharmaceutical industry is under huge pressure to address the high attrition rates in drug development. With around 90% of candidates failing during clinical development, 1 the process is not only long and risky, but also expensive for those involved. Sci Rep 9, 18911 (2019). References Hingorani, A.D.,
Let's personalize your content